February 22, 2022
Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2021 Results Presentation and Webcast
Media
February 18, 2022
BONESUPPORT HOLDING AB (PUBL) – PUBLISHES FULL YEAR REPORT 2021
February 17, 2022
Oncopeptides publishes year-end report 2021
February 17, 2022
Targovax ASA: Fourth quarter 2021 results
February 14, 2022
Invitation to presentation of 2021 year-end results
February 10, 2022
BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for year end report 2021
February 10, 2022
Vicore’s AIR study interim analysis suggests that C21 improves lung function in IPF patients
February 09, 2022
Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 09, 2022
Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2021 results, Thursday 17 February
February 04, 2022
Hemab Therapeutics Announces First Drug Candidate: HMB-001, a Novel Bispecific Antibody with Potential for Treatment of Rare Bleeding Disorders